What is the clinical significance of a plasma copeptin level of 1.2 pmol/L?

Clinical Significance of Copeptin 1.2 pmol/L

A plasma copeptin level of 1.2 pmol/L is extremely low and essentially rules out nephrogenic diabetes insipidus (NDI), but strongly suggests either AVP deficiency (central diabetes insipidus) or primary polydipsia, requiring further diagnostic testing to differentiate between these two conditions.

Interpretation Framework

What This Level Tells You

A copeptin of 1.2 pmol/L falls far below the diagnostic threshold for NDI. According to the 2025 international expert consensus, baseline plasma copeptin levels above 21.4 pmol/L are diagnostic for NDI in adults 1. Your patient's value is approximately 18-fold lower than this threshold, making NDI extremely unlikely.

This low value places your patient in the category requiring further evaluation for AVP deficiency (central DI) versus primary polydipsia 1.

Normal Reference Context

• Normal healthy individuals have median copeptin levels around 4.2 pmol/L (range 1-13.8 pmol/L), with 97.5% having detectable levels 2
• Your patient's 1.2 pmol/L is at the lower end of the normal range, but not necessarily abnormal in isolation
• Men typically have higher levels than women 2

Diagnostic Algorithm for This Patient

Step 1: Confirm Polyuria-Polydipsia Syndrome

If your patient has polyuria/polydipsia symptoms with copeptin 1.2 pmol/L, proceed with:

Step 2: Stimulation Testing Required

Adults with plasma copeptin <21.4 pmol/L should undergo stimulation testing with either 1:

• Hypertonic saline infusion (gold standard)
• Arginine stimulation test (simpler alternative)

Step 3: Interpret Stimulated Copeptin Values

For arginine stimulation test (validated cut-offs) 3:

• ≤3.0 pmol/L at 60 minutes: 95% specificity for AVP deficiency (central DI)
• >5.2 pmol/L at 60 minutes: 97% specificity for primary polydipsia

For hypertonic saline (provides highest diagnostic accuracy, though specific cut-offs vary by protocol) 1

Critical Clinical Pitfalls

Common Misinterpretations to Avoid

1. Do not assume this is "normal" just because it falls within population reference ranges - in the context of polyuria/polydipsia, this low-normal value is diagnostically significant

2. Do not diagnose based on baseline copeptin alone when <21.4 pmol/L - stimulation testing is mandatory 1

3. Pediatric patients: The diagnostic thresholds above apply to adults; pediatric reference values are less well-established 1, 4

4. Timing matters: Ensure the sample was drawn under appropriate conditions (not after excessive water loading, which can suppress copeptin)

Differential Diagnosis Considerations

With copeptin 1.2 pmol/L and polyuria, consider 1:

• Central DI (AVP deficiency): Will respond to DDAVP
• Primary polydipsia: Will respond to water deprivation
• Acquired NDI (lithium, hypercalcemia): Would show much higher copeptin (>21.4 pmol/L)

Practical Next Steps

Immediate action: Order stimulation testing (arginine or hypertonic saline) to definitively distinguish central DI from primary polydipsia 1, 3.

While awaiting testing:

• Review medication history (lithium, diuretics)
• Check serum sodium, osmolality, and urine osmolality
• Assess for symptoms of pituitary pathology if central DI suspected

The key insight is that this low copeptin value has excluded NDI but created diagnostic uncertainty between two other conditions that require different management approaches - hence the critical need for dynamic testing rather than relying on this baseline value alone.